Silexion Therapeutics Corp (SLXN) Gross margin
Silexion Therapeutics Corp (SLXN) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to SLXNSource: SEC XBRL filings · For reference only · Not investment advice
More SLXN financial trends
SLXN RevenueSLXN Net incomeSLXN Net marginSLXN Gross profitSLXN Operating incomeSLXN Operating marginSLXN Operating cash flowSLXN Free cash flowSLXN Capital expendituresSLXN Return on equitySLXN Stock buybacksSLXN Dividends paidSLXN Total assetsSLXN Total liabilitiesSLXN Shareholders’ equitySLXN overview →